Our Slack community wanted to hear about AI-driven drug discovery, and we listened. Abraham Heifets from Atomwise joins us for a fascinating deep dive into the intersection of deep learning models and molecule binding. He describes how these methods work and how they are beginning to help create drugs for “undruggable” diseases!
Discuss on Changelog News
Join Changelog++ to support our work, get closer to the metal, and make the ads disappear!
Sponsors
Featuring
Notes and Links